PITTSBURGH (MCT) — A study has identified four proteins associated with the onset of esophageal cancer, the precursor to developing a blood test for early detection and better treatment of a particularly lethal disease.
The findings — by doctors at Allegheny Health Network, the University of Pittsburgh, Roswell Park Cancer Institute in Buffalo, N.Y., and an Amsterdam medical center — were published online Tuesday by the journal Cancer.
The federally supported study occurred over four years.
“Esophageal cancer patients often have few options available to fight this disease, and five-year survival rates are extremely low at about 15 percent,” Blair Jobe, director of Allegheny Health Network’s Esophageal and Thoracic Institute and the study’s lead researcher, said in a statement.
According to the National Cancer Institute, 18,170 cases will be diagnosed this year, and 15,450 people who have the disease will die. According to the new study, the incidence of esophageal cancer is up 600 percent since the 1970s.
(c)2014 Pittsburgh Post-Gazette
Visit the Pittsburgh Post-Gazette at www.post-gazette.com.
Distributed by MCT Information Services.